Picture of Carna Biosciences logo

4572 — Carna Biosciences News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Table: Garna Biosciences -2024 group results

Feb 10 (Reuters)- 
          Garna Biosciences Inc 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                  Year ended      Year ended        Year to         NEXT   
               Dec 31, 2024    Dec 31, 2023     Dec 31, 2025      YEAR     
                  LATEST         YEAR-AGO         COMPANY        COMPANY   
                 RESULTS          RESULTS         FORECAST     H1 FORECAST 
  Sales          636 mln           1.63           722 mln                  
               (-60.9 pct)      (+17.2 pct)     (+13.5 pct)                
  Operating     loss 2.08        loss 1.12       loss 2.13                 
  Recurring     loss 2.08        loss 1.13       loss 2.14                 
  Net
  Net           loss 2.18        loss 1.15       loss 2.15                 
  EPS        loss 121.64 yen  loss 68.62 yen  loss 112.46 yen              
  Ann Div          NIL              NIL             NIL                    
  -Q2 Div          NIL              NIL             NIL                    
  -Q4 Div          NIL              NIL             NIL                    
  
  NOTE - Garna Biosciences Inc.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4572.T

Recent news on Carna Biosciences

See all news